Activity of Boanmycin Against Colorectal Cancer

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2002 Jan 31

PMID 11819740

Citations 6

Authors

Y C Deng

Y S Zhen

S Zheng

Y C Xue

Affiliations

Soon will be listed here.

Citing Articles

Boanmycin overcomes bortezomib resistance by inducing DNA damage and endoplasmic reticulum functional impairment in multiple myeloma.

Wang J, Zhang L, Zhang P, Yuan L, Jiang J, Cheng X Biol Direct. 2025; 20(1):1.

PMID: 39757239 PMC: 11702215. DOI: 10.1186/s13062-024-00590-y.

In-depth phenotypic characterization of multicellular tumor spheroids: Effects of 5-Fluorouracil.

Virgone-Carlotta A, Lemasson M, Mertani H, Diaz J, Monnier S, Dehoux T PLoS One. 2017; 12(11):e0188100.

PMID: 29141026 PMC: 5687732. DOI: 10.1371/journal.pone.0188100.

Laparoscopic total mesorectal excision of low rectal cancer with preservation of anal sphincter: a report of 82 cases.

Zhou Z, Wang Z, Yu Y, Shu Y, Cheng Z, Li L World J Gastroenterol. 2003; 9(7):1477-81.

PMID: 12854145 PMC: 4615486. DOI: 10.3748/wjg.v9.i7.1477.

Continuous release of interleukin 12 from microencapsulated engineered cells for colon cancer therapy.

Zheng S, Xiao Z, Pan Y, Han M, Dong Q World J Gastroenterol. 2003; 9(5):951-5.

PMID: 12717836 PMC: 4611403. DOI: 10.3748/wjg.v9.i5.951.

Transforming growth factor-beta1 in invasion and metastasis in colorectal cancer.

Xiong B, Yuan H, Hu M, Zhang F, Wei Z, Gong L World J Gastroenterol. 2002; 8(4):674-8.

PMID: 12174377 PMC: 4656319. DOI: 10.3748/wjg.v8.i4.674.

References

Xu H, Zhang H . [The isolation and identification of pingyangmycin (author's transl)]. Yao Xue Xue Bao. 1980; 15(10):609-14. View

Pratesi G, Manzotti C, Tortoreto M, Audisio R, Zunino F . Differential efficacy of flavone acetic against liver versus lung metastases in a human tumour xenograft. Br J Cancer. 1991; 63(1):71-4. PMC: 1971638. DOI: 10.1038/bjc.1991.15. View

Jiang M, Zhen Y . [Antitumor activity of bleomycin A6 against human liver cancer in cell culture and in nude mice]. Yao Xue Xue Bao. 1987; 22(12):881-5. View

Feng F, Zhou L, Mang Z, Liu H, Sun Y . [Phase I clinical study of a new anticancer drug boanmycin]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1996; 18(2):143-6. View

Thirion P, Wolmark N, Haddad E, Buyse M, Piedbois P . Survival impact of chemotherapy in patients with colorectal metastases confined to the liver: a re-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analyses. Meta-Analysis Group in Cancer. Ann Oncol. 2000; 10(11):1317-20. DOI: 10.1023/a:1008365511961. View

Zhen Y, Li D, Lin F, Li Q, Tian P, Xue Y . [Study on the antitumor activities and the toxicities of zhengguangmycins A5 and A2 (author's transl)]. Yao Xue Xue Bao. 1979; 14(2):83-90. View

Seitz J, Perrier H, Giovannini M, Capodano G, Bernardini D, Bardou V . 5-Fluorouracil, high-dose folinic acid and mitomycin C combination chemotherapy in previously treated patients with advanced colorectal carcinoma. J Chemother. 1998; 10(3):258-65. DOI: 10.1179/joc.1998.10.3.258. View

Garcia-Olmo D, Garcia-Rivas M, Garcia-Olmo D, Atienzar M . Orthotopic implantation of colon carcinoma cells provides an experimental model in the rat that replicates the regional spreading pattern of human colorectal cancer. Cancer Lett. 1999; 132(1-2):127-33. DOI: 10.1016/s0304-3835(98)00174-8. View

Zhen Y, Chen Y, Yu B, Zhang H, Wu S, Du P . [Cytotoxicity of the monoclonal antibody anti-CCT2 and bleomycin A6 conjugate to leukemia cells]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1986; 8(4):272-5. View

10.

Liu J, Jiang M, Xu L, Zhen Y . [Minocycline potentiates the antimetastatic effect of boanmycin]. Yao Xue Xue Bao. 1995; 30(9):668-73. View

11.

Deng Y, Zhen Y, Zheng S, Jiang M . [Experimental studies on therapeutic effect of rat monoclonal antibody-bleomycin A6 conjugate against human colorectal cancer]. Yao Xue Xue Bao. 1993; 28(6):410-5. View

12.

Pocard M, Muleris M, Hamelin R, Salmon R, Dutrillaux B, Poupon M . Growth dependency of human colon cancer xenograft on organ environment is related with their original clinical stage. Anticancer Res. 1998; 18(4A):2743-7. View

13.

. [Therapeutic effects of pingyangmycin on malignant tumors (author's transl)]. Zhonghua Zhong Liu Za Zhi. 1979; 1(3):172-5. View

14.

Sun F, Sasson A, Jiang P, An Z, Gamagami R, Li L . An ultra-metastatic model of human colon cancer in nude mice. Clin Exp Metastasis. 1999; 17(1):41-8. DOI: 10.1023/a:1026442321295. View

15.

Hartmann J, Harstrick A, Daikeler T, Kollmannsberger C, Muller C, Seeber S . Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancer. Anticancer Drugs. 1998; 9(5):427-31. DOI: 10.1097/00001813-199806000-00009. View

16.

Deng Y . [Inhibitory effect of bleomycin A6 on human colon cancer xenografts in nude mice]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1990; 12(5):335-40. View

17.

Rho Y, Lee K, Jung J, Yoon C, An Z, Hoffman R . Efficacy of new platinum analog DPPE in an orthotopic nude mouse model of human colon cancer. Anticancer Res. 1999; 19(1A):157-61. View

18.

Zhen Y, Peng Z, Deng Y, Xu H, Chen Y, Tian P . Antitumor activity of immunoconjugates composed of boanmycin and monoclonal antibody. Chin Med Sci J. 1994; 9(2):75-80. View

19.

Peng Z, Zhen Y . [Experimental studies on the antitumor activity of monoclonal antibody--bleomycin A6 conjugate against human liver cancer]. Yao Xue Xue Bao. 1991; 26(5):331-5. View

20.

Yuan H, Li Y, Yang G, Wang K . Study on the causes of local recurrence of rectal cancer after curative resection:analysis of 213 cases. World J Gastroenterol. 2002; 4(6):527-529. PMC: 4723445. DOI: 10.3748/wjg.v4.i6.527. View